Correlation Between Mereo BioPharma and Agios Pharm
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Agios Pharm, you can compare the effects of market volatilities on Mereo BioPharma and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Agios Pharm.
Diversification Opportunities for Mereo BioPharma and Agios Pharm
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Mereo and Agios is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Agios Pharm go up and down completely randomly.
Pair Corralation between Mereo BioPharma and Agios Pharm
Given the investment horizon of 90 days Mereo BioPharma Group is expected to under-perform the Agios Pharm. In addition to that, Mereo BioPharma is 1.89 times more volatile than Agios Pharm. It trades about -0.12 of its total potential returns per unit of risk. Agios Pharm is currently generating about -0.18 per unit of volatility. If you would invest 3,581 in Agios Pharm on October 20, 2024 and sell it today you would lose (339.00) from holding Agios Pharm or give up 9.47% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mereo BioPharma Group vs. Agios Pharm
Performance |
| Timeline |
| Mereo BioPharma Group |
| Agios Pharm |
Mereo BioPharma and Agios Pharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mereo BioPharma and Agios Pharm
The main advantage of trading using opposite Mereo BioPharma and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |